JP3240600001
JP3240600001
KISSEI PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 97.406.000.000 | 88.330.000.000 | 10.3% |
| Cost of Revenue | 51.587.000.000 | 44.265.000.000 | 16.5% |
| Gross Profit | 45.818.000.000 | 44.065.000.000 | 4.0% |
| 48.745.000.000 | 38.291.000.000 | 27.3% | |
| Operating Income | -2.927.000.000 | 5.774.000.000 | 150.7% |
| Pretax Income | 16.891.000.000 | 15.610.000.000 | 8.2% |
| Net Income Common Stockholders | 13.779.000.000 | 11.961.000.000 | 15.2% |
| -- | -- | -- | |
| -- | -- | -- |